Ultrastructural changes in the myocardium of animals under conditions of simulated hyperhomocysteinemia, hyper- and hypothyroidism and their combination

Keywords: hyperthyroidism, hypothyroidism, hyperhomocysteinemia, myocardium.


Thyroid hormones have a significant impact on heart function through both genomic and non-genomic effects. Deficiency or excess of thyroid hormones leads to profound changes in the regulation of cardiac function and cardiovascular hemodynamics. The heart is the main target organ for the action of thyroid hormones and in patients with hypo- or hyperthyroidism there are marked changes in the work of the heart. The aim of the work was to establish ultrastructural changes in myocardial components in experimental hyperhomocysteinemia (HHCy) against the background of hyper- and hypothyroidism. Thiolactone HHCy was modelized by administering to animals an exogenous HCy in the form of thiolactone at a dose of 100 mg/kg body weight once a day for 28 days. Hyperthyroidism was modelized by daily administration of L-thyroxine at a dose of 200 μg/kg for the 21 days, hypothyroidism – daily administration of thiamazole at a dose of 10 mg/kg for the 21 days. Individual groups of animals were administered L-thyroxine and thiamazole in parallel with HCy. High levels of HCy adversely affected the walls of myocardial blood vessels. The lumens of hemocapillaries were plethoric, filled with erythrocytes. Changes in endotheliocytes were revealed, and cardiomyocytes contained deformed nuclei. In laboratory animals with hyperthyroidism, an increase in ultrastructural changes in the walls of blood vessels (edema of the walls of hemocapillaries, damaged cristae in mitochondria) were established. In animals that were modeled for hyperthyroidism and HHCy, more significant changes in endotheliocytes were revealed, most of the mitochondria were destroyed. More pronounced alterative changes were revealed in cardiomyocytes. An electron microscopic examination of the myocardium of animals with hypothyroidism showed significant degenerative changes in the ultrastructure of the walls of blood vessels, and hypertrophied mitochondria were also found. The combined influence of hypothyroidism and HHCy caused the most profound disturbances in the ultrastructure of cardiomyocytes and hemocapillaries in comparison with other groups of animals. The integrity of intercellular contacts was impaired, most of the mitochondria of myocytes had destroyed cristae and the outer membrane.


Afshin, A., Micha, R., Khatibzadeh, S., & Mozaffarian, D. (2014). Consumption of nuts and legumes and risk of incident ischemic heart disease, stroke, and diabetes: a systematic review and meta-analysis. The American journal of clinical nutrition, 100(1), 278-288. doi: 10.3945/ajcn.113.076901]

Gerdes, A. M. (2015). Restoration of thyroid hormone balance: a game changer in the treatment of heart failure?. American journal of physiology. Heart and circulatory physiology, 308(1), H1-H10. doi: 10.1152/ajpheart.00704.2014

Gopinathannair, R., Sullivan, R., & Olshansky, B. (2009). Tachycardia-mediated cardiomyopathy: recognition and management. Current heart failure reports, 6(4), 257-264. doi: 10.1007/s11897-009-0035-3

Goralskiy, L. P., Homich, V. Т., & Kononskiy, О. І. (2011). Fundamentals of histological technique and morphofunctional methods of research in norm and in pathology. Zhitomir: Polissya.

Gözüküçük, M., Gürsoy, A. Y., Destegül, E., Taşkın, S., & Şatıroğlu, H. (2021). Homocysteine and C-reactive Protein Levels in Women with Polycystic Ovary Syndrome. Gynecology and minimally invasive therapy, 10(4), 210-214. doi: 10.4103/GMIT.GMIT_30_20

Holmager, P., Schmidt, U., Mark, P., Andersen, U., Dominguez, H., Raymond, I., … Faber, J. (2015). Long-term L-Triiodothyronine (T3) treatment in stable systolic heart failure patients: a randomised, double-blind, cross-over, placebo-controlled intervention study. Clinical endocrinology, 83(6), 931-937. doi: 10.1111/cen.12648

Kazama, I., Mori, Y., Baba, A., & Nakajima, T. (2014). Pitting type of pretibial edema in a patient with silent thyroiditis successfully treated by angiotensin ii receptor blockade. The American journal of case reports, 15, 111-114. doi: 10.12659/AJCR.889854

Kerp, H., Hönes, G. S., Tolstik, E., Hönes-Wendland, J., Gassen, J., Moeller, L. C., … & Führer, D. (2021). Protective Effects of Thyroid Hormone Deprivation on Progression of Maladaptive Cardiac Hypertrophy and Heart Failure. Frontiers in cardiovascular medicine, 8, 683522. doi: 10.3389/fcvm.2021.683522

Lisco, G., Giagulli, V. A., Iovino, M., Zupo, R., Guastamacchia, E., De Pergola, G., … & Triggiani, V. (2021). Endocrine system dysfunction and chronic heart failure: a clinical perspective. Endocrine, 1-17. Advance online publication. doi: 10.1007/s12020-021-02912-w]

Liu, Q. H., Zhang, L. J., Wang, J., Wu, B. W., & Cao, J. M. (2021). Cardioprotection of an IK1 channel agonist on L-thyroxine induced rat ventricular remodeling. American journal of translational research, 13(8), 8683-8696.

Nechiporuk, V. & Korda, M. (2017). Metabolism of cysteine in experimental hyper- and hypothyroidism in rats. Medical and Clinical Chemistry, 19(4), 32-40. doi: 10.11603/mcch.2410-681X.2017.v0.i4.8433

Paschou, S. A., Bletsa, E., Stampouloglou, P. K., Tsigkou, V., Valatsou, A., Stefanaki, K., … & Siasos, G. (2022). Thyroid disorders and cardiovascular manifestations: an update. Endocrine, 10.1007/s12020-022-02982-4. Advance online publication. doi: 10.1007/s12020-022-02982-4]

Song, E., Kim, M., Park, S., Park, M. J., Kim, J. A., Roh, E., … & Yoo, H. J. (2021). Treatment Modality and Risk of Heart Failure in Patients With Long-Standing Graves' Disease: A Nationwide Population-Based Cohort Study. Frontiers in endocrinology, 12, 761782. doi: 10.3389/fendo.2021.761782

Stangl, G. I. (2007) Homocysteine thiolactone-induced hyperhomocysteinemia does not alter concentrations of cholesterol and SREBP-2 target gene mRNAS in rats. Exp. Biol. Med., 232(1), 81-87.

Udovcic, M., Pena, R. H., Patham, B., Tabatabai, L., & Kansara, A. (2017). Hypothyroidism and the Heart. Methodist DeBakey cardiovascular journal, 13(2), 55-59. doi: 10.14797/mdcj-13-2-55

Vale, C., Neves, J. S., von Hafe, M., Borges-Canha, M., & Leite-Moreira, A. (2019). The Role of Thyroid Hormones in Heart Failure. Cardiovascular drugs and therapy, 33(2), 179-188. doi: 10.1007/s10557-019-06870-4

Vargas-Uricoechea, H., Bonelo-Perdomo, A., & Sierra-Torres, C. H. (2014). Effects of thyroid hormones on the heart. Clinica e investigacion en arteriosclerosis: publicacion oficial de la Sociedad Espanola de Arteriosclerosis, 26(6), 296-309. doi: 10.1016/j.arteri.2014.07.003]

Yamakawa, H., Kato, T. S., Noh, J. Y., Yuasa, S., Kawamura, A., Fukuda, K., & Aizawa, Y. (2021). Thyroid Hormone Plays an Important Role in Cardiac Function: From Bench to Bedside. Frontiers in physiology, 12, 606931. doi: 10.3389/fphys.2021.606931

Zhang, Y., Dedkov, E. I., Lee, B., Li, Y., Pun, K., & Gerdes, A. M. (2014). Thyroid hormone replacement therapy attenuates atrial remodeling and reduces atrial fibrillation inducibility in a rat myocardial infarction-heart failure model. Journal of cardiac failure, 20(12), 1012-1019. doi: 10.1016/j.cardfail.2014.10.003]

How to Cite
Nechiporuk, V. M., PentyukL. О., Kovalchuk, O. V., Mazur, O. I., & Korda , M. M. (2022). Ultrastructural changes in the myocardium of animals under conditions of simulated hyperhomocysteinemia, hyper- and hypothyroidism and their combination. Reports of Morphology, 28(2), 32-39. https://doi.org/10.31393/morphology-journal-2022-28(2)-05